Log in to save to my catalogue

Can the Chronic Administration of the Combination of Buprenorphine and Naloxone Block Dopaminergic A...

Can the Chronic Administration of the Combination of Buprenorphine and Naloxone Block Dopaminergic A...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3682495

Can the Chronic Administration of the Combination of Buprenorphine and Naloxone Block Dopaminergic Activity Causing Anti-reward and Relapse Potential?

About this item

Full title

Can the Chronic Administration of the Combination of Buprenorphine and Naloxone Block Dopaminergic Activity Causing Anti-reward and Relapse Potential?

Publisher

New York: Humana Press Inc

Journal title

Molecular neurobiology, 2011-12, Vol.44 (3), p.250-268

Language

English

Formats

Publication information

Publisher

New York: Humana Press Inc

More information

Scope and Contents

Contents

Opiate addiction is associated with many adverse health and social harms, fatal overdose, infectious disease transmission, elevated health care costs, public disorder, and crime. Although community-based addiction treatment programs continue to reduce the harms of opiate addiction with narcotic substitution therapy such as methadone maintenance, th...

Alternative Titles

Full title

Can the Chronic Administration of the Combination of Buprenorphine and Naloxone Block Dopaminergic Activity Causing Anti-reward and Relapse Potential?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3682495

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3682495

Other Identifiers

ISSN

0893-7648

E-ISSN

1559-1182

DOI

10.1007/s12035-011-8206-0

How to access this item